Cargando…
Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
BACKGROUND: The article aims to compare the efficiency of minimax, optimal and admissible criteria in Simon’s and Fleming’s two-stage design. METHODS: Three parameter settings (p(1)-p(0) = 0.25–0.05, 0.30–0.10, 0.50–0.30) are designed to compare the maximum sample size, the critical values and the e...
Autores principales: | Qin, Fei, Wu, Jingwei, Chen, Feng, Wei, Yongyue, Zhao, Yang, Jiang, Zhiwei, Bai, Jianling, Yu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240995/ https://www.ncbi.nlm.nih.gov/pubmed/32434577 http://dx.doi.org/10.1186/s12874-020-01017-8 |
Ejemplares similares
-
Minimax and admissible adaptive two-stage designs in phase II clinical trials
por: Shan, Guogen, et al.
Publicado: (2016) -
Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials
por: Kim, Jongphil, et al.
Publicado: (2019) -
H∞-optimal control and related: minimax design problems
por: Başar, Tamer, et al.
Publicado: (1991) -
Restricted parameter space estimation problems: admissibility and minimaxity properties
por: van Eeden, Constance
Publicado: (2006) -
Minimax and applications
por: Du, Ding-Zhu, et al.
Publicado: (1995)